scPharmaceuticals Inc (SCPH)
4.825
+0.26
(+5.58%)
USD |
NASDAQ |
May 16, 16:00
4.83
0.00 (0.00%)
After-Hours: 20:00
scPharmaceuticals Cash from Operations (Quarterly): -17.70M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -17.70M |
| December 31, 2023 | -15.16M |
| September 30, 2023 | -13.45M |
| June 30, 2023 | -14.14M |
| March 31, 2023 | -16.49M |
| December 31, 2022 | -11.84M |
| September 30, 2022 | -8.196M |
| June 30, 2022 | -7.175M |
| March 31, 2022 | -7.369M |
| December 31, 2021 | -7.098M |
| September 30, 2021 | -5.167M |
| June 30, 2021 | -6.271M |
| March 31, 2021 | -8.615M |
| December 31, 2020 | -9.18M |
| September 30, 2020 | -4.808M |
| Date | Value |
|---|---|
| June 30, 2020 | -5.962M |
| March 31, 2020 | -7.743M |
| December 31, 2019 | -14.84M |
| September 30, 2019 | -5.578M |
| June 30, 2019 | -3.911M |
| March 31, 2019 | -6.118M |
| December 31, 2018 | -5.801M |
| September 30, 2018 | -5.465M |
| June 30, 2018 | -8.472M |
| March 31, 2018 | -9.074M |
| December 31, 2017 | -5.941M |
| September 30, 2017 | -5.884M |
| June 30, 2017 | -6.114M |
| March 31, 2017 | -4.743M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-17.70M
Minimum
Mar 2024
-3.911M
Maximum
Jun 2019
-9.534M
Average
-7.970M
Median
Cash from Operations (Quarterly) Benchmarks
| Anika Therapeutics Inc | -0.126M |
| Spero Therapeutics Inc | -17.49M |
| electroCore Inc | -2.558M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -10.48M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 29.32M |
| Cash from Financing (Quarterly) | 0.015M |
| Free Cash Flow | -60.45M |
| Free Cash Flow Per Share (Quarterly) | -0.4544 |
| Free Cash Flow to Equity (Quarterly) | -18.28M |
| Free Cash Flow Yield | -32.29% |